[Effectiveness and tolerance of aerosol disodium cromoglycate in children with bronchial asthma]. 1991

J Zarkovic, and R Angermayr, and B Covi, and H Danhorn, and E Eber, and J Emhofer, and E Hagel, and R Hirschmann, and A Klabuschnigg, and J Riedler
Universitäts-Kinderklinik, Wien.

Thirteen centres studied the efficacy and safety of nebulized cromolyn solution in 53 asthmatic children (36 m., 17 f.; mean age 4.8 +/- 1.7 years). During a fiveweek treatment period a significant reduction of asthmatic symptoms was observed by investigators daily symptom scores, as assessed by the parents, also showed a significant improvement during treatment period. In addition, there was also a marked decrease in the use of other anti-asthmatic medication (beta 2-sympathomimetics, theophylline and antihistamines). There were no side effects of nebulized cromolyn solution treatment.

UI MeSH Term Description Entries
D008297 Male Males
D009330 Nebulizers and Vaporizers Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments. Atomizers,Inhalation Devices,Inhalators,Inhalers,Vaporizers,Nebulizers,Vaporizers and Nebulizers,Atomizer,Device, Inhalation,Devices, Inhalation,Inhalation Device,Inhalator,Inhaler,Nebulizer,Vaporizer
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004205 Cromolyn Sodium A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Disodium Cromoglycate,Sodium Cromoglycate,Aarane,Bicromat Spray,Cromoglicic Acid,Cromoglycate,Cromoglycic Acid,Cromolyn,FPL-670,Intal,Lomudal,Nalcrom,Nasalcrom,Opticrom,Vicrom,Acid, Cromoglicic,Acid, Cromoglycic,Cromoglycate, Disodium,Cromoglycate, Sodium,FPL 670,FPL670
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000403 Airway Resistance Physiologically, the opposition to flow of air caused by the forces of friction. As a part of pulmonary function testing, it is the ratio of driving pressure to the rate of air flow. Airway Resistances,Resistance, Airway,Resistances, Airway
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

J Zarkovic, and R Angermayr, and B Covi, and H Danhorn, and E Eber, and J Emhofer, and E Hagel, and R Hirschmann, and A Klabuschnigg, and J Riedler
January 1977, Godisen zbornik na Medicinskiot fakultet vo Skopje,
J Zarkovic, and R Angermayr, and B Covi, and H Danhorn, and E Eber, and J Emhofer, and E Hagel, and R Hirschmann, and A Klabuschnigg, and J Riedler
June 1968, Lancet (London, England),
J Zarkovic, and R Angermayr, and B Covi, and H Danhorn, and E Eber, and J Emhofer, and E Hagel, and R Hirschmann, and A Klabuschnigg, and J Riedler
July 1968, Lancet (London, England),
J Zarkovic, and R Angermayr, and B Covi, and H Danhorn, and E Eber, and J Emhofer, and E Hagel, and R Hirschmann, and A Klabuschnigg, and J Riedler
August 1968, Lancet (London, England),
J Zarkovic, and R Angermayr, and B Covi, and H Danhorn, and E Eber, and J Emhofer, and E Hagel, and R Hirschmann, and A Klabuschnigg, and J Riedler
July 1968, Lancet (London, England),
J Zarkovic, and R Angermayr, and B Covi, and H Danhorn, and E Eber, and J Emhofer, and E Hagel, and R Hirschmann, and A Klabuschnigg, and J Riedler
August 1968, Lancet (London, England),
J Zarkovic, and R Angermayr, and B Covi, and H Danhorn, and E Eber, and J Emhofer, and E Hagel, and R Hirschmann, and A Klabuschnigg, and J Riedler
July 1968, Lancet (London, England),
J Zarkovic, and R Angermayr, and B Covi, and H Danhorn, and E Eber, and J Emhofer, and E Hagel, and R Hirschmann, and A Klabuschnigg, and J Riedler
August 1968, Lancet (London, England),
J Zarkovic, and R Angermayr, and B Covi, and H Danhorn, and E Eber, and J Emhofer, and E Hagel, and R Hirschmann, and A Klabuschnigg, and J Riedler
November 1973, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
J Zarkovic, and R Angermayr, and B Covi, and H Danhorn, and E Eber, and J Emhofer, and E Hagel, and R Hirschmann, and A Klabuschnigg, and J Riedler
December 1969, Annals of internal medicine,
Copied contents to your clipboard!